Effect of tyrosine hydroxylase inhibition on the action of 6-hydroxydopamine.
D000818:Animals; D002395:Catecholamines / Q000502:physiology; D002540:Cerebral Cortex / Q000378:metabolism; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors; D006325:Heart Atria / Q000378:metabolism; D006892:Hydroxydopamines / Q000494:pharmacology*; D007031:Hypothalamus / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009410:Nerve Degeneration / Q000187:drug effects; D009474:Neurons / Q000187:drug effects / Q000201:enzymology; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors*
D002395:Catecholamines; D006892:Hydroxydopamines; D014316:Tritium; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D009526:Nialamide; D009638:Norepinephrine